Hadn't noticed how low they had gone... nice bounce today -
VACAVILLE, Calif.--(BW HealthWire)--Oct. 31, 2000--Large Scale Biology Corporation (Nasdaq: LSBC - news) today announced that its proteomics subsidiary in Rockville, Maryland has been granted two additional US patents in its core technology, automated proteomics, the key component enabling accelerated completion of the first draft of the Human Protein Index(TM).
Together, these issued patents extend the coverage of a foundation patent issued last year and demonstrate Large Scale Biology's continued technology leadership in the field of automated quantitative proteomics. This technology is being used by LSB to develop the first comprehensive description of the human proteome: the Human Protein Index. ``The Human Protein Index provides a foundation for our efforts to accelerate development of new drug and diagnostics opportunities,'' said Leigh Anderson, CEO of Large Scale Biology's proteomics subsidiary.
These patents are part of a family of patents representing superior methodology in the world of automated proteomics. This family includes US Patent No.'s 6,123,821, 6,136,173 and 5,993,627.
Large Scale Biology Corporation is an integrated research-through manufacturing enterprise that provides novel protein-focused technologies to greatly improve the speed and productivity of life sciences discovery and development programs. Corporate offices and the Genomics and Antigenics divisions are headquartered in Vacaville, California. Large Scale Proteomics Corporation, a subsidiary originally founded as Large Scale Biology Corporation, is a leading provider of proteomic technologies to the life sciences industry, and is located in Rockville, MD. Large Scale Biology's Bioprocessing and manufacturing facilities are located in Owensboro, KY. For more information about Large Scale Biology, visit its website at www.lsbc.com. |
